CTLA-4-directed Blocking Antibody

Name
CTLA-4-directed Blocking Antibody
Accession Number
DBCAT003464
Description

Not Available

Drugs
DrugDrug Description
IpilimumabA human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma.
TremelimumabAn anti-CTLA-4 antibody used to treat unresectable hepatocellular carcinoma in combination with durvalumab.
Drugs & Drug Targets
DrugTargetType
IpilimumabCytotoxic T-lymphocyte protein 4target
TremelimumabCytotoxic T-lymphocyte protein 4target